MKI67 and neoplasm: Ivermectin significantly reduced 22RV1 tumor volume growth (n = 5, Fig. 2F), lowering Ki67 and PSA levels and increasing the γH2A.X level in tumor tissue (Fig. 2G and Supplementary Fig. S3F).